Iovance Biotherapeutics, Inc.

IOVANASDAQHealthcare● Active

$4.00

$-0.23(-5.44%)

Market Cap$1.4B

P/E Ratio—

52W High$5.63

52W Low$1.66

Avg Volume15.6M

Open$4.29

Beta0.70

Insider Trades Ownership Employees

Iovance Biotherapeutics, Inc. (IOVA) Insider Trading

Form 4 buy vs sell counts, ratio, and sentiment — switch this quarter or last 12 months; chart and transactions below.

SEC EDGAR · FMP · IOVA · as of Jun 8, 2026

Activity summary

Buy transactions

P-Purchase only

Sell transactions

12 Months

Buy/Sell ratio

0.00

Buy/Sell (by trades)

Overall sentiment

NEUTRAL

↑ Buy 0%Active transactions only · RSU vesting excluded100% Sell ↓

Iovance Biotherapeutics, Inc. insiders have shown mixed buying and selling activity over the past 12 Months.

▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · Buy = P-Purchase only · Sell = S-Sale only

As of Jun 8, 2026

IOVA insider buying and selling by quarter

IOVA insider selling · IOVA insider buying stocks · quarterly insider activity

Total insider buying (incl. awards)Total insider selling

1.4M696K0

2024 Q3

2024 Q4

2025 Q1

2025 Q2

2025 Q3

2025 Q4

2026 Q1

2026 Q2

Mobile shows last 4Q · Desktop shows full 8Q

▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · last 8 quarters

As of Jun 8, 2026

Active insiders

Most active in past 12 months · IOVA ceo insider trading

Showing all insiders · Click a card to filter the transactions table below

▸ Aggregated from reportingName · top 5 by trade count (12M) · no extra API

Recent insider transactions

IOVA executive sell shares · IOVA board member insider trading · IOVA insider trading SEC filing

Showing 52 most recent · Common Stock · Form 4 only

Scroll horizontally to see all columns

Date	Insider	Type	Shares	Price	Value	After trans.	Filing
Jun 1, 2026	Vogt Frederick G Interim CEO & General Counsel · Director	Option	41,668	—	—	571,206	Form 4
Jun 1, 2026	Vogt Frederick G Interim CEO & General Counsel · Director	Other	17,701	$3.96	$70K	553,505	Form 4
Jun 1, 2026	Puri Raj K. Chief Regulatory Officer	Option	5,469	—	—	244,699	Form 4
Jun 1, 2026	Puri Raj K. Chief Regulatory Officer	Other	2,508	$3.96	$10K	242,191	Form 4
Jun 1, 2026	GRAF FINCKENSTEIN FRIEDRICH Chief Medical Officer	Option	8,790	—	—	140,747	Form 4
Jun 1, 2026	GRAF FINCKENSTEIN FRIEDRICH Chief Medical Officer	Other	4,473	$3.96	$18K	136,274	Form 4
Jun 1, 2026	BILINSKY IGOR COO	Option	8,790	—	—	134,556	Form 4
Jun 1, 2026	BILINSKY IGOR COO	Other	4,473	$3.96	$18K	130,083	Form 4
May 11, 2026	Kirby Daniel Gordon Chief Commercial Officer	Option	10,000	—	—	149,381	Form 4
May 11, 2026	Kirby Daniel Gordon Chief Commercial Officer	Other	2,435	$3.70	$9K	146,946	Form 4
Mar 5, 2026	Vogt Frederick G Interim CEO & General Counsel · Director	Option	62,493	—	—	556,293	Form 4
Mar 5, 2026	Vogt Frederick G Interim CEO & General Counsel · Director	Other	26,755	$4.58	$123K	529,538	Form 4
Mar 5, 2026	GRAF FINCKENSTEIN FRIEDRICH Chief Medical Officer	Option	31,246	—	—	148,477	Form 4
Mar 5, 2026	GRAF FINCKENSTEIN FRIEDRICH Chief Medical Officer	Other	16,520	$4.58	$76K	131,957	Form 4
Mar 5, 2026	Puri Raj K. Chief Regulatory Officer	Option	39,059	—	—	257,590	Form 4
Mar 5, 2026	Puri Raj K. Chief Regulatory Officer	Other	18,360	$4.58	$84K	239,230	Form 4
Mar 5, 2026	BILINSKY IGOR COO	Option	31,246	—	—	142,394	Form 4
Mar 5, 2026	BILINSKY IGOR COO	Other	16,628	$4.58	$76K	125,766	Form 4
Mar 2, 2026	Vogt Frederick G Interim CEO & General Counsel · Director	Option	52,087	—	—	516,609	Form 4
Mar 2, 2026	Vogt Frederick G Interim CEO & General Counsel · Director	Other	22,809	$3.79	$86K	493,800	Form 4
Mar 2, 2026	BILINSKY IGOR COO	Option	12,307	—	—	118,051	Form 4
Mar 2, 2026	BILINSKY IGOR COO	Other	6,903	$3.79	$26K	111,148	Form 4
Mar 2, 2026	Puri Raj K. Chief Regulatory Officer	Option	5,470	—	—	221,329	Form 4
Mar 2, 2026	Puri Raj K. Chief Regulatory Officer	Other	2,798	$3.79	$11K	218,531	Form 4
Mar 2, 2026	GRAF FINCKENSTEIN FRIEDRICH Chief Medical Officer	Option	12,697	—	—	124,353	Form 4

Vogt Frederick G

Interim CEO & General Counsel · Director

Option

Date

Jun 1

41,668

Price

—

Value

—

View Form 4 on SEC.gov

Vogt Frederick G

Interim CEO & General Counsel · Director

Other

Date

Jun 1

17,701

Price

$3.96

Value

$70K

View Form 4 on SEC.gov

Puri Raj K.

Chief Regulatory Officer

Option

Date

Jun 1

5,469

Price

—

Value

—

View Form 4 on SEC.gov

Puri Raj K.

Chief Regulatory Officer

Other

Date

Jun 1

2,508

Price

$3.96

Value

$10K

View Form 4 on SEC.gov

GRAF FINCKENSTEIN FRIEDRICH

Chief Medical Officer

Option

Date

Jun 1

8,790

Price

—

Value

—

View Form 4 on SEC.gov

GRAF FINCKENSTEIN FRIEDRICH

Chief Medical Officer

Other

Date

Jun 1

4,473

Price

$3.96

Value

$18K

View Form 4 on SEC.gov

BILINSKY IGOR

COO

Option

Date

Jun 1

8,790

Price

—

Value

—

View Form 4 on SEC.gov

BILINSKY IGOR

COO

Other

Date

Jun 1

4,473

Price

$3.96

Value

$18K

View Form 4 on SEC.gov

Kirby Daniel Gordon

Chief Commercial Officer

Option

Date

May 11

10,000

Price

—

Value

—

View Form 4 on SEC.gov

Kirby Daniel Gordon

Chief Commercial Officer

Other

Date

May 11

2,435

Price

$3.70

Value

$9K

View Form 4 on SEC.gov

Vogt Frederick G

Interim CEO & General Counsel · Director

Option

Date

Mar 5

62,493

Price

—

Value

—

View Form 4 on SEC.gov

Vogt Frederick G

Interim CEO & General Counsel · Director

Other

Date

Mar 5

26,755

Price

$4.58

Value

$123K

View Form 4 on SEC.gov

GRAF FINCKENSTEIN FRIEDRICH

Chief Medical Officer

Option

Date

Mar 5

31,246

Price

—

Value

—

View Form 4 on SEC.gov

GRAF FINCKENSTEIN FRIEDRICH

Chief Medical Officer

Other

Date

Mar 5

16,520

Price

$4.58

Value

$76K

View Form 4 on SEC.gov

Puri Raj K.

Chief Regulatory Officer

Option

Date

Mar 5

39,059

Price

—

Value

—

View Form 4 on SEC.gov

Puri Raj K.

Chief Regulatory Officer

Other

Date

Mar 5

18,360

Price

$4.58

Value

$84K

View Form 4 on SEC.gov

BILINSKY IGOR

COO

Option

Date

Mar 5

31,246

Price

—

Value

—

View Form 4 on SEC.gov

BILINSKY IGOR

COO

Other

Date

Mar 5

16,628

Price

$4.58

Value

$76K

View Form 4 on SEC.gov

Vogt Frederick G

Interim CEO & General Counsel · Director

Option

Date

Mar 2

52,087

Price

—

Value

—

View Form 4 on SEC.gov

Vogt Frederick G

Interim CEO & General Counsel · Director

Other

Date

Mar 2

22,809

Price

$3.79

Value

$86K

View Form 4 on SEC.gov

BILINSKY IGOR

COO

Option

Date

Mar 2

12,307

Price

—

Value

—

View Form 4 on SEC.gov

BILINSKY IGOR

COO

Other

Date

Mar 2

6,903

Price

$3.79

Value

$26K

View Form 4 on SEC.gov

Puri Raj K.

Chief Regulatory Officer

Option

Date

Mar 2

5,470

Price

—

Value

—

View Form 4 on SEC.gov

Puri Raj K.

Chief Regulatory Officer

Other

Date

Mar 2

2,798

Price

$3.79

Value

$11K

View Form 4 on SEC.gov

GRAF FINCKENSTEIN FRIEDRICH

Chief Medical Officer

Option

Date

Mar 2

12,697

Price

—

Value

—

View Form 4 on SEC.gov

⚡ = value ≥ $1M · Award/Option price shows — · formType=4 · securityName=Common Stock · url → sec.gov/Archives/edgar

1 / 3

▸ Source: SEC EDGAR · Form 4 filings · ⚡ = value ≥ $1M · Award/Option price shows —

About IOVA insider trading

IOVA insider trades

Iovance Biotherapeutics, Inc. (IOVA) insider trading data is sourced from SEC Form 4 filings submitted by corporate insiders, including Vogt Frederick G (Interim CEO & General Counsel · Director), GRAF FINCKENSTEIN FRIEDRICH (Chief Medical Officer), BILINSKY IGOR (COO). Over the past 12 months, 5 insiders have filed transactions with the SEC. IOVA insiders have been mixed buying and selling, which may reflect pre-scheduled Rule 10b5-1 plan executions.

For Iovance Biotherapeutics, Inc.'s institutional ownership breakdown and insider ownership percentage, see the Ownership tab → Ownership tab →

Buy/Sell signal logic

acquisitionOrDisposition field:

A = Acquisition (buy) · D = Disposition (sell)

RSU vesting (M-Exempt) excluded from sentiment

Form 4SEC filing required within 2 business days of any insider transaction

10b5-1Pre-scheduled trading plan that allows insiders to sell on autopilot

Open MktDirect purchase or sale on the open market (excludes awards, options)

Ownership SEC filings Financial statements Price history Forecast & ratings Earnings

Frequently asked questions

IOVA insider trading · 5 questions

The insiders of Iovance Biotherapeutics, Inc. (IOVA) include executives and directors such as Vogt Frederick G (Interim CEO & General Counsel · Director), GRAF FINCKENSTEIN FRIEDRICH (Chief Medical Officer), BILINSKY IGOR (COO), among others. Over the past 12 months, 5 insiders have filed Form 4 transactions with the SEC. Insider transactions are required to be reported within 2 business days of the trade date.

IOVA board member insider tradingwho are IOVA insidersIOVA insider rosterIovance Biotherapeutics, Inc. executives insider activity

▸ Source: FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · acquisitionOrDisposition A=Buy, D=Sell · RSU vesting (M-Exempt) excluded from sentiment bar · As of Jun 8, 2026